Medicare Enrolled
Dr. John Devlin, M.D.
Hematology & Oncology · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Devlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Devlin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Devlin
Dr. John Devlin is a hematology & oncology specialist in Bryn Mawr, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Devlin performed 185,876 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Devlin received a total of $25,097 from 102 pharmaceutical and/or device companies across 1335 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Devlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in PA
$25,097 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗185,876
Medicare services
Top 1% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
61,200 | $2 | $10 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
35,250 | $1 | $2 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
23,371 | $10 | $25 |
| Pembrolizumab injection (Keytruda) | 18,600 | $43 | $89 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,450 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 15,360 | $18 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,833 | $1 | $50 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
2,544 | $89 | $370 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
2,055 | $13 | $55 |
| Anti-nausea injection (ondansetron/Zofran) | 1,392 | $0 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
889 | $99 | $220 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
828 | $5 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
706 | $11 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
665 | $109 | $322 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
641 | $1 | $15 |
| Injection, granisetron hydrochloride, 100 mcg | 491 | $0 | $25 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
464 | $4 | $25 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
464 | $2 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
326 | $1 | $13 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
184 | $1 | $17 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
169 | $54 | $160 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
146 | $2 | $30 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
135 | $24 | $75 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
114 | $27 | $125 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
98 | $61 | $185 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
77 | $53 | $170 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
68 | $24 | $73 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
58 | $20 | $75 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
50 | $1 | $9 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
49 | $75 | $172 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $65 | $196 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $142 | $267 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
40 | $69 | $70 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
33 | $11 | $35 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
23 | $138 | $310 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $75 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
19.7% high complexity
78.9% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,097
Total received (2018-2024)
Avg $3,585/year across 7 years
Top 13% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
102
Companies
1,335
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,991
2023
$4,099
2022
$2,740
2021
$2,118
2020
$2,696
2019
$4,752
2018
$3,701
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$474
PFIZER INC.
$409
Novartis Pharmaceuticals Corporation
$344
E.R. Squibb & Sons, L.L.C.
$319
Astellas Pharma US Inc
$308
ABBVIE INC.
$279
Daiichi Sankyo Inc.
$268
Merck Sharp & Dohme LLC
$229
Eisai Inc.
$199
Incyte Corporation
$182
Celgene Corporation
$160
Ipsen Biopharmaceuticals, Inc
$158
Genmab U.S., Inc.
$143
Bayer Healthcare Pharmaceuticals Inc.
$132
Genentech USA, Inc.
$95
Karyopharm Therapeutics Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$86
Janssen Biotech, Inc.
$83
ARRAY BIOPHARMA INC
$82
Exelixis Inc.
$80
GENZYME CORPORATION
$77
Mirati Therapeutics, Inc.
$67
SHIELD THERAPEUTICS INC
$62
Gilead Sciences, Inc.
$62
Adaptive Biotechnologies Corporation
$57
Alexion Pharmaceuticals, Inc.
$49
PharmaEssentia USA Corporation
$46
SOBI, INC
$46
SERVIER PHARMACEUTICALS LLC
$46
Janssen Pharmaceuticals, Inc
$45
Blueprint Medicines Corporation
$43
Stemline Therapeutics Inc.
$37
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
JAZZ PHARMACEUTICALS INC.
$26
Pharming Healthcare, Inc.
$25
Aveo Pharmaceuticals, Inc.
$23
Apellis Pharmaceuticals, Inc.
$21
MorphoSys, US Inc.
$21
Agios Pharmaceuticals, Inc.
$20
BeiGene USA, Inc.
$19
Ferring Pharmaceuticals Inc.
$18
GlaxoSmithKline, LLC.
$17
Lilly USA, LLC
$14
Sirtex Medical Inc
$6
Top 3 companies account for 24.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,067
E.R. Squibb & Sons, L.L.C.
$1,692
PFIZER INC.
$1,004
Daiichi Sankyo Inc.
$972
Novartis Pharmaceuticals Corporation
$971
Celgene Corporation
$943
Lilly USA, LLC
$903
Janssen Biotech, Inc.
$868
Genentech USA, Inc.
$783
Amgen Inc.
$770
Pharmacyclics LLC, An AbbVie Company
$750
Incyte Corporation
$748
Merck Sharp & Dohme Corporation
$738
Astellas Pharma US Inc
$728
Janssen Pharmaceuticals, Inc
$677
GENZYME CORPORATION
$606
Eisai Inc.
$545
Ipsen Biopharmaceuticals, Inc
$427
ABBVIE INC.
$403
Takeda Pharmaceuticals U.S.A., Inc.
$390
Merck Sharp & Dohme LLC
$375
Athenex Pharmaceutical Division, LLC
$350
Alexion Pharmaceuticals, Inc.
$316
Exelixis Inc.
$299
Taiho Oncology, Inc.
$273
Seagen Inc.
$272
Seattle Genetics, Inc.
$260
Foundation Medicine, Inc.
$230
Genmab U.S., Inc.
$206
EISAI INC.
$202
ARRAY BIOPHARMA INC
$197
Puma Biotechnology, Inc.
$186
Pharmacyclics LLC, an AbbVie Company
$183
Mirati Therapeutics, Inc.
$182
Karyopharm Therapeutics Inc.
$178
Blueprint Medicines Corporation
$169
EMD Serono, Inc.
$168
Bayer Healthcare Pharmaceuticals Inc.
$167
Servier Pharmaceuticals LLC
$159
Gilead Sciences, Inc.
$158
Pharmacosmos Therapeutics Inc.
$150
BeiGene USA, Inc.
$128
Janssen Scientific Affairs, LLC
$125
Amarin Pharma Inc.
$124
Stemline Therapeutics Inc.
$116
Bayer HealthCare Pharmaceuticals Inc.
$115
Kyowa Kirin, Inc.
$113
GlaxoSmithKline, LLC.
$112
Teva Pharmaceuticals USA, Inc.
$111
Celltrion USA Inc.
$101
COMSORT, Inc
$100
TESARO, Inc.
$99
AMAG Pharmaceuticals, Inc.
$97
Regeneron Healthcare Solutions, Inc.
$95
Clovis Oncology, Inc.
$86
AbbVie Inc.
$86
AbbVie, Inc.
$84
Lexicon Pharmaceuticals, Inc.
$82
PharmaEssentia USA Corporation
$82
Dova Pharmaceuticals
$81
TerSera Therapeutics LLC
$74
SOBI, INC
$71
Rigel Pharmaceuticals, Inc.
$68
Coherus Biosciences Inc.
$66
SHIELD THERAPEUTICS INC
$62
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Agios Pharmaceuticals, Inc.
$60
MorphoSys, US Inc.
$58
Adaptive Biotechnologies Corporation
$57
Alnylam Pharmaceuticals Inc.
$53
Aveo Pharmaceuticals, Inc.
$53
SERVIER PHARMACEUTICALS LLC
$46
JAZZ PHARMACEUTICALS INC.
$43
Fresenius Kabi USA, LLC
$39
Sobi, Inc
$36
Bio Products Laboratory USA, Inc.
$35
Heron Therapeutics, Inc.
$35
G1 Therapeutics, Inc.
$35
RECORDATI_RARE_DISEASES_INC.
$35
Jazz Pharmaceuticals Inc.
$34
Immunomedics, Inc.
$30
Verastem, Inc.
$30
Kite Pharma, Inc.
$27
Fortovia Therapeutics, Inc.
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Pharming Healthcare, Inc.
$25
TOLMAR Pharmaceuticals, Inc.
$24
MEDIVATION FIELD SOLUTIONS LLC
$24
Helsinn Therapeutics (U.S.), Inc.
$22
Telix Pharmaceuticals
$22
Sandoz Inc.
$22
Prometheus Laboratories Inc.
$22
Apellis Pharmaceuticals, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$21
Acceleron Pharma, Inc.
$20
Spectrum Pharmaceuticals Inc.
$20
Octapharma USA, Inc.
$20
Ferring Pharmaceuticals Inc.
$18
Sumitomo Pharma America, Inc.
$17
EUSA Pharma (US) LLC
$15
INSYS Therapeutics Inc
$13
Sirtex Medical Inc
$6
Top 3 companies account for 19.0% of all-time payments
Associated products mentioned in payments ›
6 · ACCRUFER · ADCETRIS · ADSTILADRIN · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aranesp · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARBAGLU · COSELA · CYRAMZA · Cabometyx · Coagadex · Columvi · Copiktra · DARZALEX · DIFICID · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gammaplex · Gazyva · Halaven · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kabiven · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · NOXAFIL · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Onivyde · Orserdu · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Proleukin · Prolia · REBLOZYL · RETEVMO · RUCONEST · Reblozyl · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · STELARA · SUSTOL · SUTENT · SYNDROS · Sodium Chloride · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VEGZELMA · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vascepa · Vectibix · Venclexta · Voranigo · Vyloy · XALKORI · XARELTO · XERMELO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZIEXTENZO · ZINPLAVA · ZOLADEX · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
289
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Devlin is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Devlin experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Devlin performed 61,200 darbepoetin injection (aranesp) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Devlin receive payments from pharmaceutical companies?
Yes. Dr. Devlin received a total of $25,097 from 102 companies across 1,335 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Devlin's costs compare to other hematology & oncology specialists in Bryn Mawr?
Dr. Devlin's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Devlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Bryn Mawr
Browse hematology & oncology specialists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology